428 Views | 663 Downloads
Address correspondence to Martin L. Moore, martin.moore@emory.edu.
We thank the Emory Children's Pediatric Research Center flow cytometry core supported by Children's Healthcare of Atlanta (CHOA).
We thank Edward Walsh for the monoclonal antibody to the RSV N protein and Ursula Buchholz and Karl-Klaus Conzelmann for the BSR-T7/5 cell line. We also thank Nancy Ulbrandt (MedImmune) for providing motavizumab antibody.
M.L.M. and Emory University are entitled to licensing fees derived from various agreements that Emory has entered into related to products used in this research described in this paper. This study could affect the personal financial status of M.L.M. The terms of this agreement have been reviewed and approved by Emory University in accordance with its conflict-of-interest policies.
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) provided funding to Michael M. Moore under grant numbers 1R01AI087798 and 1U19AI095227.
This study was also supported by funds from Emory University and CHOA.
Additional support was provided by the NIH through Emory Vaccinology Training Grant T32AI074492 (Christopher C. Stobart), by Emory and CHOA under joint grant number 33515 (Michael G. Currier, Christopher C. Stobart, Sujin Lee, and Martin L. Moore), and by Emory through Nelson Memorial Fund R6336510 (Anne L. Hotard and Martin L. Moore).
© 2015, American Society for Microbiology.